NATURE’S SUNSHINE PRODUCTS, INC. Payments to Acquire Available-for-sale Securities
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Payments to Acquire Available-for-sale Securities of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2018-03-16
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire available-for-sale securities for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire available-for-sale securities for the quarter ending 2015-03-31 was $15.00K, a 150.00% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire available-for-sale securities for the quarter ending 2014-12-31 was $703.00K, a 328.66% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire available-for-sale securities for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire available-for-sale securities for fiscal 2017 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire available-for-sale securities for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire available-for-sale securities for fiscal 2015 was $3.00K, a 99.58% decline from fiscal 2014.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire available-for-sale securities for fiscal 2014 was $721.00K, a 63.12% increase from fiscal 2013.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-16 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-03-16 | |||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | |||
| 2015-12-31 | $3.00K 10-K · filed 2018-03-16 | |||
| 2015-03-31 | $15.00K 10-Q · filed 2016-05-10 | $718.00K derived: sum of 2 quarters · filed 2017-03-14 | $718.00K derived: sum of 3 quarters · filed 2017-03-14 | $730.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $703.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $703.00K derived: sum of 2 quarters · filed 2017-03-14 | $715.00K derived: sum of 3 quarters · filed 2017-03-14 | $721.00K 10-K · filed 2017-03-14 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $12.00K derived: sum of 2 quarters · filed 2015-11-06 | $18.00K 10-Q · filed 2015-11-06 | $182.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $18.00K 10-Q · filed 2015-08-10 | $182.00K derived: sum of 3 quarters · filed 2016-03-14 | $385.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $6.00K 10-Q · filed 2015-05-11 | $170.00K derived: sum of 2 quarters · filed 2016-03-14 | $373.00K derived: sum of 3 quarters · filed 2016-03-14 | $365.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $367.00K derived: sum of 2 quarters · filed 2016-03-14 | $359.00K derived: sum of 3 quarters · filed 2016-03-14 | $442.00K 10-K · filed 2016-03-14 |
| 2013-09-30 | $203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $195.00K derived: sum of 2 quarters · filed 2014-11-06 | $278.00K 10-Q · filed 2014-11-06 | $255.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $75.00K 10-Q · filed 2014-08-07 | $52.00K derived: sum of 3 quarters · filed 2015-03-13 | $71.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $83.00K 10-Q · filed 2014-05-08 | $60.00K derived: sum of 2 quarters · filed 2015-03-13 | $79.00K derived: sum of 3 quarters · filed 2015-03-13 | $40.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$4.00K derived: sum of 2 quarters · filed 2015-03-13 | -$43.00K derived: sum of 3 quarters · filed 2015-03-13 | $174.00K 10-K · filed 2015-03-13 |
| 2012-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$20.00K derived: sum of 2 quarters · filed 2013-11-08 | $197.00K 10-Q · filed 2013-11-08 | $3.30M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | -$39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $178.00K 10-Q · filed 2013-08-09 | $3.28M derived: sum of 3 quarters · filed 2014-03-17 | $4.30M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $217.00K 10-Q · filed 2013-05-09 | $3.32M derived: sum of 2 quarters · filed 2014-03-17 | $4.34M derived: sum of 3 quarters · filed 2014-03-17 | |
| 2011-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $4.12M derived: sum of 2 quarters · filed 2014-03-17 | $6.97M 10-K · filed 2014-03-17 | |
| 2011-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $3.87M 10-Q · filed 2012-11-06 | ||
| 2011-06-30 | $2.85M 10-Q · filed 2012-08-03 | |||
| 2010-12-31 | $3.44M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |